SCHEMBL7568086

SCHEMBL7568086

Nc1nc2c(c(=O)[nH]1)NCN2CCC(=O)NCc1ccc2c(c1)OCO2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
HPGD P15428 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT2A Q03164 4/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
ADRB2 P07550 1/20 0.44
MEN1 O00255 2/20 0.44
USP2 O75604 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568100 0.77 TDP1 (0.56) POLBHPGDTDP1MAPK1ALDH1A1
SCHEMBL7567089 0.77 HPRT1 (0.54) MAPK1USP2
SCHEMBL7570074 0.76 HPRT1 (0.53) HPGDALDH1A1KMT2A
SCHEMBL7570897 0.74 CA1 (0.50) POLBALDH1A1L3MBTL1CA1CA2
SCHEMBL7982326 0.74 HPRT1 (0.51) TDP1ALDH1A1GLA
SCHEMBL7576799 0.74 HPRT1 (0.51) KMT2AMEN1
SCHEMBL7570451 0.73 HPRT1 (0.53) HPGDTDP1ALDH1A1KMT2ACYP3A4
SCHEMBL7570941 0.73 HPRT1 (0.49)
SCHEMBL7571914 0.73 HPRT1 (0.49) KMT2ACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL7570987 0.72 MEN1 (0.51) ALDH1A1KMT2ACYP1A2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US claimed
EP-1237890-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES Neotherapeutics, Inc. (US) 2002-09-11 EP disclosed
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US disclosed
WO-2001029039-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES NEOTHERAPEUTICS, INC. (US) 2001-04-26 WO disclosed